318 results match your criteria: "University of Texas-M. D. Anderson Hospital and Tumor Institute[Affiliation]"
Cancer
November 1988
Department of Clinical Radiotherapy, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Between 1968 and 1985, 46 patients with renal cell carcinoma metastatic to the brain parenchyma were treated with radiation. Thirty-nine received whole-brain radiation, mostly 30 Gy in ten fractions. Symptoms improved in 30% of evaluable patients.
View Article and Find Full Text PDFCancer Res
October 1988
Department of Head and Neck Surgery, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston 77030.
Int J Cancer
October 1988
Department of Tumor Biology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
A rat hybridoma producing IgM monoclonal antibody (MAb) GP21:56 was generated with specificity for a high-molecular-weight, mucin-like glycoprotein (gp580) present on highly metastatic 13762NF rat mammary adenocarcinoma cells. The hybridoma was made by fusing rat Y3 Ag1.2.
View Article and Find Full Text PDFCancer Res
October 1988
Department of Hematology, University of Texas-M. D. Anderson Hospital and Tumor Institute, Houston 77030.
Fresh tumor samples from 27 patients with large cell lymphoma, either previously untreated (26 patients) or minimally treated (one patient), were processed for cytogenetic studies. Cytogenetic abnormalities were observed in all patients, most commonly in chromosomes 1, 3, 7, 12, 14, 17, and 18. Nine chromosomal breakpoints appeared frequently: 14q32 in 14 instances; 18q21 in seven; 9p13-21, 17p11-13, and 3q21-23 in six each; 1p11-21 in five instances; 1p36 in four; and 2p21-23 in three.
View Article and Find Full Text PDFCancer
October 1988
Department of Head and Neck Surgery, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston.
To define the biologic characteristics of head and neck cancer in the young adult, the clinical course of 83 previously untreated patients less than or equal to 40 years of age with head and neck cancer was reviewed retrospectively. Their course was compared to that in a randomly chosen, concurrently treated, site-matched and stage-matched older head and neck cancer population (matched control). Patterns of recurrence as well as overall disease-free survival in each of the two populations were not significantly different.
View Article and Find Full Text PDFJ Clin Oncol
October 1988
Department of Hematology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston.
From July 1980 to November 1985, 109 patients with acute myelogenous and lymphoblastic leukemia who had reached a complete remission (CR) following induction treatment were assigned to a study comparing marrow transplantation with chemotherapy as a postremission treatment. Sixty-nine patients did not have a human leukocyte antigen (HLA)-identical donor, and therefore served as chemotherapy controls; 40 patients had HLA-identical donors, and therefore were assigned to the transplant arm. Of these, 23 were transplanted in first remission and 17 were not.
View Article and Find Full Text PDFJ Laryngol Otol
October 1988
Department of Pathology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston.
The parotid gland is added to the list of parenchymal organs, notably the pancreas, in which osteoclast-like cells appear as constituent cells in their neoplasms. The cells' role in the neoplasms is a reactive one or, more rarely, as an integral element in an osteoclast-type giant cell neoplasm or so-called osteoclastoma. Distinctive in histological appearance, the osteoclast-type giant cell neoplasm is a malignant lesion that, to date, has been described only in the pancreas and parotid glands.
View Article and Find Full Text PDFCancer
September 1988
Department of Pathology, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston 77030.
Fifty-one patients were evaluated by fine-needle aspiration (FNA) as part of the diagnosis, staging, and management of osteosarcoma. All patients had histologic confirmation of osteosarcoma. Five patients underwent two aspirations each; thus, the total number of aspirates reviewed was 56.
View Article and Find Full Text PDFCancer
September 1988
Department of Pathology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
This study of 93 patients with Stage I nonseminomatous and mixed germ cell testicular tumors who were placed in a surveillance study following orchiectomy was designed to evaluate pathologic prognostic factors. Follow-up was at least 12 months post-orchiectomy except for one patient who was followed for 9 months. Lymphatic invasion was identified in 26 patients, 62% of whom developed distant metastases; metastasis developed in only 18% of 67 patients without lymphatic invasion (P less than 0.
View Article and Find Full Text PDFJ Pediatr
September 1988
Department of Pediatrics, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Sixty consecutive evaluable children with recurrent primary tumors of the central nervous system were treated with a regimen of vincristine, nitrogen mustard, procarbazine, and prednisone over a 12-year period. Tumor types included medulloblastoma (19), brain-stem glioma (16), astrocytoma (13), and a miscellaneous glioma (12). Responses and sustained survivals were achieved.
View Article and Find Full Text PDFRadiat Res
September 1988
Department of Medical Oncology, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston 77030.
Radiat Res
September 1988
Department of Medical Oncology, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston 77030.
We investigated the role of initial DNA and chromosome damage in determining the radiosensitivity difference between the variant murine leukemic lymphoblast cell lines L5178Y-S (sensitive) and L5178Y-R (resistant) and the difference in cell cycle-dependent variations in radiosensitivity of L5178Y-S cells. We measured initial DNA damage (by the neutral filter elution method) and chromosome damage (by the premature chromosome condensation method) and compared them with survival (measured by cloning) for both cell lines synchronized in G1 or G2 phase of the cell cycle (by centrifugal elutriation) and irradiated with low doses of X rays (up to 10 Gy). The initial yield of DNA and chromosome damage in G2 L5178Y-S cells was almost twice that in G1 L5178Y-S cells and G1 or G2 L5178Y-R cells.
View Article and Find Full Text PDFJ Cell Physiol
September 1988
Department of Tumor Biology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Radiother Oncol
September 1988
University of Texas M.D. Anderson Hospital and Tumor Institute, Department of Radiation Physics, Houston 77030.
The physical characteristics of the M.D. Anderson Hospital (MDAH) clinical neutron beam are presented.
View Article and Find Full Text PDFJPEN J Parenter Enteral Nutr
December 1988
Department of General Surgery, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
The effect of a protein-free diet (PF) or a restricted intake of chow (RI) and subsequent host repletion with total parenteral nutrition (PF-TPN, RI-TPN) on tumor growth and polyamine metabolism of fibrosarcoma-bearing rats was examined. Host weight was significantly reduced by PF and RI. Tumor growth was reduced in malnourished rats with the PF regimen resulting in the greatest decrease.
View Article and Find Full Text PDFActa Cytol
October 1988
Department of Pathology, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston.
The value of mouse monoclonal antibody (MAb) HMB-45 for the diagnosis of melanoma was retrospectively evaluated in cytologic preparations. Twenty-two (68.7%) of the 32 melanoma cases studied reacted with MAb HMB-45 while none of the 36 nonmelanoma tumors stained with this antibody.
View Article and Find Full Text PDFInvest New Drugs
September 1988
Department of Medical Oncology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Fourteen evaluable patients with small cell bronchogenic carcinoma received tiazofurin, an inhibitor of inosine monophosphate dehydrogenase, that progressed after one combination chemotherapy. No objective remission was observed at the dosage of 800 mg/m2 for 5 consecutive days. Toxicity was moderate.
View Article and Find Full Text PDFBiochem Biophys Res Commun
August 1988
Department of Medical Oncology, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston.
Am J Clin Oncol
August 1988
Department of Medical Oncology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
We assessed antitumor activity and toxic effects of cisplatin and 5-day continuous infusion vinblastine in 25 evaluable patients with metastatic breast carcinoma refractory to one or more chemotherapeutic regimens. We administered cisplatin at 70 mg/m2 i.v.
View Article and Find Full Text PDFThe human chromosomal assignments of genes of the creatine kinase (CK) family--loci for brain (CKBB), muscle (CKMM), and mitochondrial (CKMT) forms--were studied by Southern filter hybridization analysis of DNAs isolated from a human x rodent somatic cell hybrid clone panel. Probes for the 3'-noncoding sequences of human CKBB and CKMM hybridized concordantly only to DNAs from somatic cell hybrids containing chromosomes 14 and 19, respectively. Thus the earlier assignment of the gene coding for the CKBB isozyme to chromosome 14 was confirmed by molecular means, as was the provisional assignment of CKMM to the long arm of chromosome 19.
View Article and Find Full Text PDFLaryngoscope
August 1988
Department of Head and Neck Surgery, University of Texas M. D. Anderson Hospital and Tumor Institute of Houston.
Anaerobic organisms are thought to be an important source of wound infection in head and neck oncologic surgery. Antibiotic prophylaxis consisting of agents specific for anaerobes combined with broad-spectrum agents that provide coverage for other well-recognized pathogens should be an effective combination regimen for this group of patients. We conducted a prospective, randomized study comparing the efficacy of prophylaxis using combination of metronidazole and cefazolin-designated group A, to prophylaxis using cefazolin alone-group B, for patients undergoing oncologic procedures of the head and neck.
View Article and Find Full Text PDFCancer Genet Cytogenet
August 1988
Department of Experimental Radiotherapy, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston 77030.
It is theorized that tumors may be initiated by two methods: by an error affecting one or several oncogenes, or by an error affecting one or several of the genes controlling the stability of the genome. The majority of cells that misexpress an oncogene(s) and that later form a tumor probably form nonevolving benign tumors. A minority of these cells with an activated oncogene(s) (or one of the descendant cells) may also come to misexpress a stability gene(s).
View Article and Find Full Text PDFNucl Med Commun
August 1988
Department of Nuclear Medicine, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston 77030.
We have evaluated immunoscintigraphy in cancer patients using four 111In-labelled murine monoclonal antibodies (MoAb): 96.5 (anti-P97 of melanoma), ZME-018 (anti-high molecular weight antibody of melanoma), ZCE-025 (anti-CEA for colon cancer) and PAY-276 (anti-prostatic acid phosphatase for prostatic cancer). The effect of increasing the doses of unlabelled MoAb (co-infused with 1 mg labelled MoAb) on the relative body distribution of each labelled MoAb was assessed.
View Article and Find Full Text PDFBlood
August 1988
Department of Clinical Immunology and Biological Therapy, Hematology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Chronic myelogenous leukemia (CML) is characterized by a reciprocal translocation between chromosomes 9 and 22. The breakpoints on chromosome 22 are clustered within a 5.8-kilobase (kb) DNA fragment known as the breakpoint cluster region (bcr), which encodes part of a functionally active gene.
View Article and Find Full Text PDF